631 results on '"Preisser, Felix"'
Search Results
2. Impact of persistent PSA after salvage radical prostatectomy: a multicenter study
3. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study
4. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis
5. Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy
6. Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms
7. Metastatic Sites’ Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review
8. The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?
9. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis
10. Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer
11. Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center
12. PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer
13. MP58-13 LONG-TERM BIOCHEMICAL RECURRENCE IN PATIENTS WITH LYMPH NODE INVASION UNDERGOING RADICAL PROSTATECTOMY AND LYMPH NODE DISSECTION
14. PD17-03 DESCRIPTIVE TUMOR CHARACTERISTICS OF 992 CONSECUTIVE PATIENTS WHO UNDERWENT STAGING WITH PSMA PET/CT BEFORE RADICAL PROSTATECTOMY
15. PD17-06 ASSESSMENT OF PSMA PET/CT FINDINGS IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR ISUP GRADE GROUP 1 PROSTATE CANCER
16. PD17-04 CORRELATION OF INTRAPROSTATIC SUVMAX DURING PSMA PET/CT AND ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY
17. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy
18. Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
19. Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy
20. Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior Biopsies
21. Implementation of Intraoperative Frozen Section During Radical Prostatectomy: Short-term Results from a German Tertiary-care Center
22. Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer
23. The Impact of Anxiety and Depression on Surgical and Functional Outcomes in Patients Who Underwent Radical Prostatectomy
24. Impact of Age on Perioperative Outcomes at Radical Prostatectomy: A Population-Based Study
25. Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups
26. Intermediate-risk Prostate Cancer: Stratification and Management
27. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis
28. PSMA-PET/CT beim Prostatakarzinom*
29. The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management
30. Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age
31. Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer
32. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes
33. Validation of the Social Security Administration Life Tables (2004–2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database
34. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy
35. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma
36. The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis
37. Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence
38. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study
39. Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma
40. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients
41. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years
42. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy
43. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals
44. Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study
45. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder
46. Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis
47. Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?
48. Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer
49. Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma
50. Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.